The results showed that the mean plasma concentration of IGFBP2 in lung cancer patients (388.12±261.00 ng/ml) was significantly higher than that in healthy controls (219.30±172.84 ng/ml, P=2.4 x 10-7) (Figure 1A). Here, IGFBP2 is linked to lung cancer.